Concurrent Investment Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2001015 Tampa, FL

Position in VRTX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$5,039,325

+$804,341 QoQ

Shares Held

10,145

+7.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#476

of 1,735 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Concurrent Investment Advisors, LLC holds $48,406,067 across 42 Biotechnology names. VRTX ranks #3 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	306,280	$11,947,982
2	ROIV	Roivant Sciences Ltd.	190,938	$6,757,295
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	10,145	$5,039,325
4	CRSP	CRISPR Therapeutics AG	90,537	$4,937,887
5	ALNY	Alnylam Pharmaceuticals, Inc.	7,521	$2,264,046
6	BEAM	Beam Therapeutics Inc.	63,879	$2,192,326
7	REGN	Regeneron Pharmaceuticals, Inc.	2,839	$1,770,229
8	EXEL	Exelixis, Inc.	22,791	$1,240,057

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,039,325	10,145	+7.0%	Shares	Sole	2026-07-27
2026-03-31	$4,234,984	9,484	-2.6%	Shares	Sole	2026-04-21
2025-12-31	$4,413,005	9,734	+242.9%	Shares	Sole	2026-01-29
2025-09-30	$1,111,865	2,839	-9.0%	Shares	Sole	2025-10-27
2025-06-30	$1,389,024	3,120	-2.9%	Shares	Sole	2025-07-25
2025-03-31	$1,557,726	3,213	+55.1%	Shares	Sole	2025-04-29
2024-12-31	$834,394	2,072	0.0%	Shares	Sole	2025-02-03
2024-09-30	$963,645	2,072	+35.3%	Shares	Sole	2024-10-30
2024-06-30	$717,610	1,531	+19.0%	Shares	Sole	2024-07-30
2024-03-31	$537,978	1,287	+93.2%	Shares	Sole	2024-05-07
2023-12-31	$270,988	666	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.